368 related articles for article (PubMed ID: 30636092)
1. Clinical features and determinants of chronicity in hepatitis E virus infection.
Narayanan S; Abutaleb A; Sherman KE; Kottilil S
J Viral Hepat; 2019 Apr; 26(4):414-421. PubMed ID: 30636092
[TBL] [Abstract][Full Text] [Related]
2. [Chronic Hepatitis E Virus Infection and Treatment in Organ Transplant Recipients].
Chen S; Wei F; Wu T; Xia N
Bing Du Xue Bao; 2015 May; 31(3):293-8. PubMed ID: 26470537
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis E virus: An ancient hidden enemy in Latin America.
Fierro NA; Realpe M; Meraz-Medina T; Roman S; Panduro A
World J Gastroenterol; 2016 Feb; 22(7):2271-83. PubMed ID: 26900289
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.
Aslan AT; Balaban HY
World J Gastroenterol; 2020 Oct; 26(37):5543-5560. PubMed ID: 33071523
[TBL] [Abstract][Full Text] [Related]
5. Genotype 4 hepatitis E virus is a cause of chronic hepatitis in renal transplant recipients in Hong Kong.
Sridhar S; Chan JFW; Yap DYH; Teng JLL; Huang C; Yip CCY; Hung IFN; Tang SCW; Lau SKP; Woo PCY; Yuen KY
J Viral Hepat; 2018 Feb; 25(2):209-213. PubMed ID: 28984015
[No Abstract] [Full Text] [Related]
6. Chronic Hepatitis E Viral Infection After Liver Transplantation: A Regression of Fibrosis After Antiviral Therapy.
Mazzola A; Tran Minh M; Charlotte F; Hdiji A; Bernard D; Wendum D; Calmus Y; Conti F
Transplantation; 2017 Sep; 101(9):2083-2087. PubMed ID: 28376032
[TBL] [Abstract][Full Text] [Related]
7. Plasma Hepatitis E Virus Kinetics in Solid Organ Transplant Patients Receiving Ribavirin.
Lhomme S; DebRoy S; Kamar N; Abravanel F; Metsu D; Marion O; Dimeglio C; Cotler SJ; Izopet J; Dahari H
Viruses; 2019 Jul; 11(7):. PubMed ID: 31323954
[TBL] [Abstract][Full Text] [Related]
8. Acute and Persistent Hepatitis E Virus Genotype 3 and 4 Infection: Clinical Features, Pathogenesis, and Treatment.
Kamar N; Pischke S
Cold Spring Harb Perspect Med; 2019 Jul; 9(7):. PubMed ID: 29735575
[TBL] [Abstract][Full Text] [Related]
9. Treatment of autochthonous acute hepatitis E with short-term ribavirin: a multicenter retrospective study.
Péron JM; Abravanel F; Guillaume M; Gérolami R; Nana J; Anty R; Pariente A; Renou C; Bureau C; Robic MA; Alric L; Vinel JP; Izopet J; Kamar N
Liver Int; 2016 Mar; 36(3):328-33. PubMed ID: 26179015
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis E virus co-infection in HIV-infected patients in Foggia and Naples in southern Italy.
Scotto G; Grisorio B; Filippini P; Ferrara S; Massa S; Bulla F; Martini S; Filippini A; Tartaglia A; Lo Muzio L; Fazio V
Infect Dis (Lond); 2015; 47(10):707-13. PubMed ID: 25994453
[TBL] [Abstract][Full Text] [Related]
11. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity.
Cao D; Cao QM; Subramaniam S; Yugo DM; Heffron CL; Rogers AJ; Kenney SP; Tian D; Matzinger SR; Overend C; Catanzaro N; LeRoith T; Wang H; Piñeyro P; Lindstrom N; Clark-Deener S; Yuan L; Meng XJ
Proc Natl Acad Sci U S A; 2017 Jul; 114(27):6914-6923. PubMed ID: 28630341
[TBL] [Abstract][Full Text] [Related]
12. Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Todesco E; Mazzola A; Akhavan S; Abravanel F; Poynard T; Roque-Afonso AM; Peytavin G; Marcelin AG; Calmus Y; Lecuyer L; Guillemain R; Conti F
Antivir Ther; 2018; 23(5):463-465. PubMed ID: 29504509
[TBL] [Abstract][Full Text] [Related]
13. Successful Treatment of Chronic Hepatitis E After an Orthotopic Liver Transplant With Ribavirin Monotherapy.
Klein F; Neuhaus R; Hofmann J; Rudolph B; Neuhaus P; Bahra M
Exp Clin Transplant; 2015 Jun; 13(3):283-6. PubMed ID: 24779678
[TBL] [Abstract][Full Text] [Related]
14. Chronic Infection With Camelid Hepatitis E Virus in a Liver Transplant Recipient Who Regularly Consumes Camel Meat and Milk.
Lee GH; Tan BH; Teo EC; Lim SG; Dan YY; Wee A; Aw PP; Zhu Y; Hibberd ML; Tan CK; Purdy MA; Teo CG
Gastroenterology; 2016 Feb; 150(2):355-7.e3. PubMed ID: 26551551
[TBL] [Abstract][Full Text] [Related]
15. Prevalence, morbidity, and therapy of hepatitis E virus infection in pediatric renal allograft recipients.
Cordts SE; Schneble L; Schnitzler P; Wenzel JJ; Vinke T; Rieger S; Fichtner A; Tönshoff B; Höcker B
Pediatr Nephrol; 2018 Jul; 33(7):1215-1225. PubMed ID: 29500631
[TBL] [Abstract][Full Text] [Related]
16. A mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients.
Debing Y; Gisa A; Dallmeier K; Pischke S; Bremer B; Manns M; Wedemeyer H; Suneetha PV; Neyts J
Gastroenterology; 2014 Nov; 147(5):1008-11.e7; quiz e15-6. PubMed ID: 25181691
[TBL] [Abstract][Full Text] [Related]
17. The burden of hepatitis E among patients with haematological malignancies: A retrospective European cohort study.
von Felden J; Alric L; Pischke S; Aitken C; Schlabe S; Spengler U; Giordani MT; Schnitzler P; Bettinger D; Thimme R; Xhaard A; Binder M; Ayuk F; Lohse AW; Cornelissen JJ; de Man RA; Mallet V
J Hepatol; 2019 Sep; 71(3):465-472. PubMed ID: 31108159
[TBL] [Abstract][Full Text] [Related]
18. Advances in Hepatitis E Virus Biology and Pathogenesis.
Lin S; Zhang YJ
Viruses; 2021 Feb; 13(2):. PubMed ID: 33572257
[TBL] [Abstract][Full Text] [Related]
19. Chronic hepatitis E virus infection is specifically associated with an interferon-related transcriptional program.
Moal V; Textoris J; Ben Amara A; Mehraj V; Berland Y; Colson P; Mege JL
J Infect Dis; 2013 Jan; 207(1):125-32. PubMed ID: 23072754
[TBL] [Abstract][Full Text] [Related]
20. Calcineurin inhibitors stimulate and mycophenolic acid inhibits replication of hepatitis E virus.
Wang Y; Zhou X; Debing Y; Chen K; Van Der Laan LJ; Neyts J; Janssen HL; Metselaar HJ; Peppelenbosch MP; Pan Q
Gastroenterology; 2014 Jun; 146(7):1775-83. PubMed ID: 24582714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
